Gland Pharma Limited has informed the Exchange regarding Appointment of Mr Xiao Le as the Chief Investment Officer for Gland Pharma International PteLtd (Wholly- owned subsidiary of Gland Pharma Limited), effective November 09, 2026 |SUBJECT: Appointment
Source link
Related Posts
The British School New Delhi and UCL Host Leadership Development Conference for School Leaders
The British School New Delhi, in collaboration with the UCL Centre for Educational Leadership at the UCL Institute of…
Indian Overseas Bank
Investor Relations Cell has informed the Exchange about Board Meeting to be held on 26-Oct-2026 to inter-alia consider and approve…
APL Apollo Tubes Limited
APL Apollo Tubes Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026|SUBJECT:…